References
Rudis MI, Brandl KM (2000) Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med 28:3746–3750
Broyles JE, Brown RO, Vehe KL, Nolly RJ, Luther RW (1991) Pharmacist interventions improve fluid balance in fluid-restricted patients requiring parenteral nutrition. DICP 25:119–122
Devlin JW, Holbrook AM, Fuller HD (1997) The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann Pharmacother 31:689–695
Simpson JH, Lynch R, Grant J, Alroomi L (2004) Reducing medication errors in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed 89:F480–482
Vogel Kahmann I, Burki R, Denzler U, Hofler A, Schmid B, Splisgardt H (2003) [Incompatibility reactions in the intensive care unit. Five years after the implementation of a simple "colour code system"]. Anaesthesist 52:409–412
Kaye J, Ashline V, Erickson D, Zeiler K, Gavigan D, Gannon L, Wynne P, Cooper J, Kittle W, Sharma K, Morton J (2000). Critical care bug team: a multidisciplinary team approach to reducing ventilator-associated pneumonia. Am J Infect Control 28:197–201
Calabrese AD, Erstad BL, Brandl K, Barletta JF, Kane SL, Sherman DS (2001) Medication administration errors in adult patients in the ICU. Intensive Care Med 27:1592–1598
Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J, Hyzy R, Zarowitz BJ (1997) A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 25:575–583
Dager WE, Albertson TE (1992) Impact of therapeutic drug monitoring of intravenous theophylline regimens on serum theophylline concentrations in the medical intensive care unit. Ann Pharmacother 26:1287–1291
Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JL, Bates, DW (1999) Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282:267–270
Lazarou J, Pomeranz BH, Coery PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279:1200–1205
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367
Kane SL, Weber RJ, Dasta JF (2003) The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 29:691–698
McMullin ST, Hennenfent JA, Ritchie DJ, Huey HY, Lonergan TP, Schaiff RA, Tonn ME, Bailey TC (1999) A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 59:2306–2309
Dell. Available at http://www.dell.de. Accessed 18.10.2005
Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
Klopfer JD, Einarson TR (1990) Acceptance of pharmacists' suggestions by prescribers: a literature review. Hosp Pharm 25:830–832, 834–836
Nurminen, M. (1997) [Slaves of the p-value?]. Duodecim 113:277–80
Lilly: Financial Ratios. Available at http://investor.lilly.com/ratios.cfm. Accessed 24.01.2005
Lycos: Financial Ratios. Available at http://finance.lycos/qc/research/marketguide.aspx?pg=fin&symbols=NYSE:PFE. Accessed 13.01.2005
Acknowledgements
We are indebted for his assistance in preparing this manuscript to Professor Ross J. Baldessarini, MD, Harvard Medical School, Boston, Massachusetts, who (even without the prior necessity for financial analyses) has for many years been active in the integration of psychiatric specialists, PharmD clinical pharmacists and their trainees into the Psychopharmacology Service that he directs at the McLean Division of Massachusetts General Hospital.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hartmann, M., Meier-Hellmann, A. How to increase return on investment of the intensive care pharmacist – fear of flying. Intensive Care Med 32, 511–515 (2006). https://doi.org/10.1007/s00134-006-0072-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-006-0072-2